Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
Journal of Clinical Medicine|August 27, 2021
Protocol Biopsies on de novo Renal-Transplants at 3 Months after Surgery: Impact on 5-Year Transplant SurvivalFlorian Terrec, Johan Noble, Hamza Naciri-Bennani, et al.Transplant Immunology|May 10, 2019
Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocolPaolo Malvezzi, Clara Fischman, Guillaume Rigault, et al.Clinical Biochemistry|December 31, 2022
Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipientsAurélie Truffot, Jean-François Jourdil, Elodie Veyret-Gautier, et al.Journal of Clinical Apheresis|March 30, 2021
Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorptionThomas Jouve, Raphaël Marlu, Hamza Naciri Bennani, et al.International Journal of Immunopathology and Pharmacology|March 12, 2025
Impact of tacrolimus on interferon gamma ELISpot assay results for the assessment of T-cell immunity: Proof-of-conceptAurélie Truffot, Jules Weinhard, Pauline Dessaud, et al.Transplantation Direct|February 13, 2020
Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic ParametersFlorian Terrec, Thomas Jouve, Hamza Naciri-Bennani, et al.Journal of Personalized Medicine|March 28, 2024
Is There a Place for Apheresis in the Management of Idiopathic Membranous Nephropathy? A Report of Three Cases and Literature ReviewHamza Naciri Bennani, Augustin Twite Banza, Diane Giovannini, et al.Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 23, 2018
Systematic Screening Using Luminex for De Novo C3d Fixing of Class II Donor-Specific Antibodies Is Correlated With Luminex Mean Fluorescence Intensity in Renal Transplant PatientsMorgane Villemaire, Thomas Jouve, Anne Bourdin, et al.Acta Diabetologica|November 27, 2015
RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-upBenoit Franko, Pierre-Yves Benhamou, Céline Genty, et al.Transplantation Direct|April 29, 2021
Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant CandidatesMélanie Daligault, Béatrice Bardy, Johan Noble, et al.Pageof 10